In California, twelve more users of Xarelto have filed injury claims against defendants Johnson & Johnson, Janssen Pharm. and Bayer Corp with the complaints alleging complications including gastrointestinal bleeding, and suffering a stroke in one case according to Law360.
The March 16th filing, adds to the legal woes the defendants face against their popular blood thinning medication, as they attempt to fend off a number of pending lawsuits for alleged uncontrolled bleeding events and other health complaints the risks of which patients and doctors may not have been properly warned of at the time of prescription.
The anticoagulant Xarelto (rivaroxaban) was approved in 2011 to help hip and knee patients prevent blood clots following replacement surgery and protect against clotting and stroke in patients with atrial fibrillation.
A number of claims were made during the marketing of the medication to consumers relating to it being superior to the previous generation of anticoagulants including Warfarin (coumadin).
[NOTE TO BLEEDING PROBLEM SUFFERERS: There is more complete information on finding out if you qualify to file a claim (and how to get a free legal review) in the Xarelto Lawsuit Injury Claims case resource which can be accessed here. The Xarelto case page goes into further detail about the current claims and how to find out if you qualify to file a claim for injuries you suffered.]
The lack of an antidote similar to Vitamin-K in the case of Warfarin, has led to a number of serious side effects including: uncontrollable bleeding events, deep vein thrombosis, gastrointestinal bleeding, and brain hemorrhages and pulmonary embolism, according to court documents from pending litigation.
The latest lawsuits filed alleging Xarelto caused the users to suffer GI bleeding events and stroke will likely only increase awareness of the pending litigation and lead to more patients coming forward to sue who believe the health injuries they suffered were caused by their Xarelto use.